Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903).

NCT00291655 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
130
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

UCB Pharma